Next Quarterly Earnings
Tuesday, November 10, 2026
CW 46
After-Hours
In 75 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Janux Therapeutics
Janux Therapeutics is a U.S. biotechnology company specializing in the development of innovative T-cell engagers for cancer therapy. Through its proprietary tumor-activation platform, Janux optimizes oncology treatments to improve efficacy and safety in the treatment of solid tumors.
Frequently asked questions
When will Janux Therapeutics report its next quarterly earnings?
Janux Therapeutics is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Janux Therapeutics last report quarterly earnings?
Janux Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.35 USD.
How often has Janux Therapeutics beaten expectations?
Janux Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Janux Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
-1.6%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Janux Therapeutics
Country
🇺🇸
More Financial Information